FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to a pharmaceutical composition having anxiolytic activity. Pharmaceutical composition for preparing a solid dosage form contains N-benzyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide and pharmaceutically acceptable excipients in said ratio, wt. %: N-benzyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide - 1.0; microcrystalline cellulose - 88.0; cross-linked polyvinylpyrrolidone - 4.0; polyvinylpyrrolidone - 6.0; magnesium stearate 1.0.
EFFECT: invention provides extending the range of medications possessing anxiolytic action, increases bioavailability of the active substance due to the excipients used.
3 cl, 7 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION BASED ON N-BUTYL-N-METHYL-1-PHENYLPYRROLO[1,2-a]PYRAZINE-3-CARBOXAMIDE | 2023 |
|
RU2811453C1 |
| 1-ARYLPYRROLO[1,2A]PYRAZINE-3-CARBOXAMIDES WITH NEUROPSYCHOTROPIC ACTIVITY | 2014 |
|
RU2572076C2 |
| PYRROLO[1,2-A]PYRAZINE-CONTAINING LIGANDS OF THE 18 KDA TRANSLOCATOR PROTEIN WITH ANXIOLYTIC ACTIVITY | 2022 |
|
RU2812083C2 |
| DIPHENYLPYRROLO[1,2-A]PYRAZINE-3-CARBOXAMIDES-COMPOUNDS HAVING NEUROPSYCHOTROPIC ACTIVITY, METHODS FOR PREPARING THEM | 2018 |
|
RU2734240C2 |
| LIGANDS OF TRANSLOCATOR PROTEIN TSPO, HAVING ANTIDEPRESSANT AND NOOTROPIC ACTIVITY | 2015 |
|
RU2699568C2 |
| SUBSTITUTED DIPEPTIDES WITH NEUROPSYCHOTROPIC ACTIVITY | 2014 |
|
RU2573823C2 |
| TRIPEPTIDE HAVING NEUROPSYCHOTROPIC ACTIVITY | 2023 |
|
RU2823022C1 |
| PHARMACEUTICAL COMPOSITION OF N-(6-PHENYLHEXANOYL)GLYCYL-L-TRYPTOPHAN AMIDE IN SOLID DOSAGE FORM | 2013 |
|
RU2602742C2 |
| PROLONGED ACTION PHARMACEUTICAL COMPOSITION BASED ON 5-ETHOXY-2-[2-(MORPHOLINO)-ETHYLTHIO]BENZIMIDAZOLE DIHYDROCHLORIDE AND/OR BASE (APHOBAZOLUM) | 2017 |
|
RU2694837C2 |
| CARDIOTROPIC AGENT WITH ANXIOLYTIC AND ANALGESIC PROPERTIES | 2020 |
|
RU2773018C2 |
